Management of postinfarct ventricular tachycardias
J M Miller1, M A Coppess, G T Altemose
1Indiana University School of Medicine, Krannert Institute of Cardiology, Indianapolis, USA. jmiller6@iupui.edu
Cardiology Clinics
|June 13, 2000
Summary
Treatments for postinfarct ventricular tachycardia (VT) have evolved, improving patient outcomes. Current and emerging therapies offer better quality of life, shifting focus from survival to innovative care.
Area of Science:
- Cardiology
- Clinical Medicine
- Medical Innovation
Background:
- The clinical presentation of patients experiencing postinfarct ventricular tachycardia (VT) has undergone significant changes over the last 20 years.
- Existing therapeutic strategies for postinfarct VT have been refined, alongside the introduction of novel treatment modalities.
Purpose of the Study:
- To analyze the evolving clinical landscape of postinfarct VT.
- To highlight advancements in treatment options for postinfarct VT.
- To discuss the impact of new therapies on patient prognosis and quality of life.
Main Methods:
- Review of clinical data and treatment outcomes for postinfarct VT patients over two decades.
- Analysis of the efficacy and safety of established and emerging therapeutic approaches.
- Comparative assessment of treatment challenges and patient management strategies.
Main Results:
- Significant evolution in the clinical profile of patients with postinfarct VT.
- Substantial improvements in existing treatments and development of new therapeutic options.
- Postinfarct VT is becoming a more manageable condition due to expanded treatment availability.
Conclusions:
- The management of postinfarct VT has transitioned from a primary focus on mortality reduction to enhancing patient survival and quality of life.
- Ongoing therapeutic innovations are expected to further improve the long-term outlook for individuals with postinfarct VT.
- Keeping abreast of novel treatment strategies is crucial for optimizing care in postinfarct VT patients.
More Related Videos
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
08:19Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
Published on: July 12, 2022
Related Concept Videos
01:17Increased pulse rate
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
01:29Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...